These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 19605599)
1. Antiretroviral therapy restores diversity in the T-cell receptor Vbeta repertoire of CD4 T-cell subpopulations among human immunodeficiency virus type 1-infected children and adolescents. Yin L; Kou ZC; Rodriguez C; Hou W; Goodenow MM; Sleasman JW Clin Vaccine Immunol; 2009 Sep; 16(9):1293-301. PubMed ID: 19605599 [TBL] [Abstract][Full Text] [Related]
2. CD4+ and CD8+ T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy-naive adolescents. Pahwa S; Chitnis V; Mitchell RM; Fernandez S; Chandrasekharan A; Wilson CM; Douglas SD AIDS Res Hum Retroviruses; 2003 Jun; 19(6):487-95. PubMed ID: 12882658 [TBL] [Abstract][Full Text] [Related]
3. T-Cell receptor Vbeta repertoire CDR3 length diversity differs within CD45RA and CD45RO T-cell subsets in healthy and human immunodeficiency virus-infected children. Kou ZC; Puhr JS; Rojas M; McCormack WT; Goodenow MM; Sleasman JW Clin Diagn Lab Immunol; 2000 Nov; 7(6):953-9. PubMed ID: 11063505 [TBL] [Abstract][Full Text] [Related]
4. Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children. Kou ZC; Puhr JS; Wu SS; Goodenow MM; Sleasman JW J Infect Dis; 2003 Feb; 187(3):385-97. PubMed ID: 12552422 [TBL] [Abstract][Full Text] [Related]
6. Alterations in T-cell receptor Vbeta repertoire of CD4 and CD8 T lymphocytes in human immunodeficiency virus-infected children. Kharbanda M; McCloskey TW; Pahwa R; Sun M; Pahwa S Clin Diagn Lab Immunol; 2003 Jan; 10(1):53-8. PubMed ID: 12522039 [TBL] [Abstract][Full Text] [Related]
7. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience. Gray CM; Schapiro JM; Winters MA; Merigan TC AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710 [TBL] [Abstract][Full Text] [Related]
8. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children. Resino S; Galán I; Bellón JM; Navarro ML; León JA; Muñoz-Fernandez MA J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220 [TBL] [Abstract][Full Text] [Related]
9. Early increase of CD4+ CD45RA+ and CD4+ CD95- cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients. Silvestri G; Munoz-Calleja C; Bagnarelli P; Piedimonte G; Clementi M; Montroni M Clin Exp Immunol; 1998 Jan; 111(1):3-11. PubMed ID: 9472655 [TBL] [Abstract][Full Text] [Related]
10. T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy. Arizcorreta A; Márquez M; Fernández-Gutiérrez C; Guzmán EP; Brun F; Rodríguez-Iglesias M; Girón-González JA Clin Exp Immunol; 2006 Nov; 146(2):270-7. PubMed ID: 17034579 [TBL] [Abstract][Full Text] [Related]
11. Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy. Kostense S; Raaphorst FM; Notermans DW; Joling J; Hooibrink B; Pakker NG; Danner SA; Teale JM; Miedema F AIDS; 1998 Dec; 12(18):F235-40. PubMed ID: 9875570 [TBL] [Abstract][Full Text] [Related]
12. Specific patterns of CD4-associated immunosenescence in vertically HIV-infected subjects. Méndez-Lagares G; Díaz L; Correa-Rocha R; León Leal JA; Ferrando-Martínez S; Ruiz-Mateos E; Pozo-Balado MM; Gurbindo MD; de José MI; Muñoz-Fernández MA; Leal M; Pacheco YM Clin Microbiol Infect; 2013 Jun; 19(6):558-65. PubMed ID: 22735071 [TBL] [Abstract][Full Text] [Related]
13. T cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, T cell receptor repertoire and anti-HIV T-lymphocyte activity. Giovannetti A; Pierdominici M; Mazzetta F; Salemi S; Marziali M; Kuonen D; Iebba F; Lusi EA; Cossarizza A; Aiuti F Clin Exp Immunol; 2001 Apr; 124(1):21-31. PubMed ID: 11359439 [TBL] [Abstract][Full Text] [Related]
14. T-cell receptor diversity is selectively skewed in T-cell populations of patients with Wiskott-Aldrich syndrome. Wu J; Liu D; Tu W; Song W; Zhao X J Allergy Clin Immunol; 2015 Jan; 135(1):209-16. PubMed ID: 25091438 [TBL] [Abstract][Full Text] [Related]
15. HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy. Resino S; Galán I; Pérez A; León JA; Seoane E; Gurbindo D; Muñoz-Fernandez MA Clin Exp Immunol; 2004 Sep; 137(3):570-7. PubMed ID: 15320908 [TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of TCR Vβ repertoire in patients with 22q11.2 deletion syndrome. McLean-Tooke A; Barge D; Spickett GP; Gennery AR Scand J Immunol; 2011 Jun; 73(6):577-85. PubMed ID: 21323691 [TBL] [Abstract][Full Text] [Related]
17. Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers. Resino S; Abad ML; Navarro J; Bellón JM; Sánchez-Ramón S; Angeles Muñoz-Fernández M Clin Exp Immunol; 2003 Jan; 131(1):130-7. PubMed ID: 12519396 [TBL] [Abstract][Full Text] [Related]
18. Plasticity of the Immune System in Children Following Treatment Interruption in HIV-1 Infection. Sandgaard KS; Margetts B; Attenborough T; Gkouleli T; Adams S; Holm M; Gibb D; Gibbons D; Giaquinto C; De Rossi A; Bamford A; Palma P; Chain B; Gkazi AS; Klein N Front Immunol; 2021; 12():643189. PubMed ID: 34475868 [TBL] [Abstract][Full Text] [Related]
19. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among HIV-1 infected individuals before and after antiretroviral therapy. Giacoia-Gripp CB; Neves I; Galhardo MC; Morgado MG J Clin Immunol; 2005 Mar; 25(2):116-26. PubMed ID: 15821888 [TBL] [Abstract][Full Text] [Related]
20. Supranormal thymic output up to 2 decades after HIV-1 infection. Aguilera-Sandoval CR; Yang OO; Jojic N; Lovato P; Chen DY; Boechat MI; Cooper P; Zuo J; Ramirez C; Belzer M; Church JA; Krogstad P AIDS; 2016 Mar; 30(5):701-11. PubMed ID: 26730570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]